Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund

A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.

A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.

clinical trial design
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Opinion: Why Most TBI Studies Fail
Opinion: Why Most TBI Studies Fail
Donald Stein | Feb 24, 2016
Thoughts on how to redesign clinical trials for traumatic brain injury
NCI Gets Personal
NCI Gets Personal
Bob Grant | Jun 2, 2015
The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.
Clinical Matchmaker
Clinical Matchmaker
Kate Yandell | Jun 1, 2015
Enrolling the right patient population could be key to a successful clinical trial.